首页> 外文期刊>Current Science: A Fortnightly Journal of Research >HIV-1 protease tethered heterodimer-pepstatin-A complex: NMR characterization
【24h】

HIV-1 protease tethered heterodimer-pepstatin-A complex: NMR characterization

机译:HIV-1蛋白酶束缚的异二聚体-胃抑素-A复合物:NMR表征

获取原文
获取原文并翻译 | 示例
       

摘要

Wild type HIV-1 protease is a homodimer that plays a crucial role in the function of the virus and hence has been a target of anti HIV (human immunodeficiency virus) drug design. However, heterodimers generated by different mutations in the individual monomers have been seen to have different characteristics and thus have been used as macromolecular inhibitors of enzyme activity. Further, during the course of clinical treatment, it is conceivable that more than one mutant species exist inside a cell, resulting in the production of both homo- and heterodimers of the enzyme. In this context we have investigated here by NMR, the characteristic features of a particular heterodimer complexed to the peptide inhibitor pepstatin-A. The heterodimer has a GGSSG linker joining the two monomers head to tail and one of the monomers has a C95M mutation that lies in the dimerization domain. NMR backbone assignments have revealed that there is an asymmetry between the two monomer units. The secondary structural characteristics of the protein in the complex are almost identical to those in the crystal structure of the wild type homodimer protein complexed to the inhibitor, acetyl pepstatin, Thus neither the covalent linker nor the mutation seems to affect the gross solution structural features of the protease. Some local differences are, however, seen near the site of mutation. The inhibitor sitting in the active site cavity exhibits a flip-flop motion. Amide proton deuterium exchange studies reveal different local stabilities of the individual residues and also differences between the two monomer units. To our knowledge, this is the first NMR report characterizing a heterodimer of HIV-1 protease and forms a basis for future detailed investigation with different heterodimers, inhibitors, etc. [References: 53]
机译:野生型HIV-1蛋白酶是同型二聚体,在该病毒的功能中起关键作用,因此已成为抗HIV(人类免疫缺陷病毒)药物设计的目标。然而,已经发现由各个单体中的不同突变产生的异二聚体具有不同的特性,因此已被用作酶活性的大分子抑制剂。此外,在临床治疗过程中,可以想象在细胞内部存在一种以上的突变种,导致产生该酶的同二聚体和异二聚体。在这种情况下,我们在这里通过NMR研究了与肽抑制剂pepstatin-A复合的特定异二聚体的特征。异二聚体具有GGSSG接头,其将两种单体首尾相连,并且单体之一具有位于二聚化结构域中的C95M突变。 NMR主链分配表明两个单体单元之间存在不对称性。复合物中蛋白质的二级结构特征几乎与与抑制剂乙酰基胃抑素复合的野生型同型二聚体蛋白质的晶体结构相同,因此,共价接头或突变似乎都不会影响其总溶液的结构特征。蛋白酶。但是,在突变位点附近可以看到一些局部差异。坐在活动位腔中的抑制剂表现出触发器动作。酰胺质子氘交换研究揭示了各个残基的不同局部稳定性,以及两个单体单元之间的差异。据我们所知,这是第一份表征HIV-1蛋白酶异二聚体的NMR报告,并为将来使用不同的异二聚体,抑制剂等进行详细研究奠定了基础。[参考文献:53]

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号